Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Tiago Outeiro.

Newcastle AuthorsTitleYearFull text
Professor Tiago Outeiro
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells2022
Professor Tiago Outeiro
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition2022
Professor Tiago Outeiro
Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes2022
Professor Tiago Outeiro
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation2022
Chris Hatton
Dr David Koss
Dr Lauren Walker
Professor Tiago Outeiro
Professor Johannes Attems
et al.
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease2022
Professor Tiago Outeiro
Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight2022
Dr Daniel Erskine
Professor Johannes Attems
Professor Ian McKeith
Professor Tiago Outeiro
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity2022
Professor Tiago Outeiro
Alpha-Synuclein Antibody Characterization: Why Semantics Matters2021
Professor Tiago Outeiro
Alpha-synuclein oligomerization and aggregation: A model will always be a model2021
Professor Tiago Outeiro
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease2021
Professor Tiago Outeiro
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies2021
Professor Tiago Outeiro
Cancer and Parkinson's Disease: Common Targets, Emerging Hopes2021
Professor Tiago Outeiro
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo2021
Professor Tiago Outeiro
Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo2021
Professor Tiago Outeiro
DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization2021
Professor Tiago Outeiro
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo2021
Professor Tiago Outeiro
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity2021
Dr David Koss
Professor Tiago Outeiro
Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases2021
Professor Tiago Outeiro
Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation2021
Professor Tiago Outeiro
In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies2021
Professor Tiago Outeiro
JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties2021
Professor Tiago Outeiro
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats2021
Dr Daniel Erskine
Dr David Koss
Dr Viktor Korolchuk
Professor Tiago Outeiro
Professor Johannes Attems
et al.
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders2021
Professor Tiago Outeiro
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene [Nuevos nanoliposomas multifuncionales inhiben la fibrilización de la α-sinucleína, atenúan la activación de la microglía y silencian la expresión de SNCA]2021
Dr David Koss
Odeta Bondarevaite
Professor Johannes Attems
Professor Tiago Outeiro
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies2021
Professor Tiago Outeiro
Reply to: “Parkinson's Disease and COVID-19: Do We Need to Be More Patient?”2021
Professor Tiago Outeiro
Small molecule fisetin modulates alpha-Synuclein aggregation2021
Professor Tiago Outeiro
A new MAP-Rasagiline conjugate reduces α-synuclein inclusion formation in a cell model2020
Professor Tiago Outeiro
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors2020
Professor Tiago Outeiro
Are genetic and idiopathic forms of Parkinson's disease the same disease?2020
Professor Tiago Outeiro
Bioprospection of natural sources of polyphenols with therapeutic potential for redox-related diseases2020
Professor Tiago Outeiro
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization2020
Professor Tiago Outeiro
From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease2020
Professor Tiago Outeiro
Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein2020
Professor Tiago Outeiro
Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model2020
Professor Tiago Outeiro
Increased expression of myelin-associated genes in frontal cortex of SNCA overexpressing rats and Parkinson's disease patients2020
Professor Tiago Outeiro
Mechanisms of alpha-synuclein toxicity: An update and outlook2020
Professor Tiago Outeiro
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies2020
Professor Tiago Outeiro
Pharmacological modulators of tau aggregation and spreading2020
Professor Tiago Outeiro
Protein trapping leads to altered synaptic proteostasis in synucleinopathies2020
Professor Tiago Outeiro
Reply to: SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead2020
Professor Tiago Outeiro
SARS-CoV-2, immunosenescence and inflammaging: Partners in the COVID-19 crime2020
Dr David Koss
Professor Tiago Outeiro
Synucleinopathies: Where we are and where we need to go2020
Professor Tiago Outeiro
The courage to change science2020
Professor Tiago Outeiro
The Interplay Between Proteostasis Systems and Parkinson's Disease2020
Professor Tiago Outeiro
The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders2020
Dr David Koss
Professor Tiago Outeiro
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies2019
Professor Tiago Outeiro
A2AR-induced transcriptional deregulation in astrocytes: An in vitro study2019
Professor Tiago Outeiro
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity2019
Professor Tiago Outeiro
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod12019
Dr David Koss
Mary Johnson
Professor Johannes Attems
Professor Tiago Outeiro
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies2019
Professor Tiago Outeiro
Dr David Koss
Dr Daniel Erskine
Dr Lauren Walker
Dr Marzena Kurzawa-Akanbi
et al.
Dementia with Lewy bodies: an update and outlook2019
Professor Tiago Outeiro
Epigenetics of the Synapse in Neurodegeneration2019
Professor Tiago Outeiro
Glycation in Huntington's disease: A possible modifier and target for intervention2019
Professor Tiago Outeiro
Investigating targets for neuropharmacological intervention by molecular dynamics simulations2019
Professor Tiago Outeiro
Monitoring α-synuclein multimerization in vivo2019
Dr Thomas Meyer
Professor Johannes Attems
Professor Tiago Outeiro
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein2019
Professor Tiago Outeiro
Seeding variability of different alpha synuclein strains in synucleinopathies2019
Professor Tiago Outeiro
Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved2019
Professor Tiago Outeiro
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding2019
Professor Tiago Outeiro
Synuclein Meeting 2019: where we are and where we need to go2019
Professor Tiago Outeiro
The Parkinson’s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration2019
Professor Tiago Outeiro
The role of LRRK2 in cell signalling2019
Professor Tiago Outeiro
The synthetic cannabinoid JWH-018 modulates Saccharomyces cerevisiae energetic metabolism2019
Professor Tiago Outeiro
Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function2018
Professor Tiago Outeiro
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson's disease2018
Professor Tiago Outeiro
Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View2018
Professor Tiago Outeiro
Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast2018
Professor Tiago Outeiro
Implications of fALS Mutations on Sod1 Function and Oligomerization in Cell Models2018
Professor Tiago Outeiro
Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells2018
Professor Tiago Outeiro
Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration2018
Professor Tiago Outeiro
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons2018
Professor Tiago Outeiro
Zebrafish as an animal model for drug discovery in Parkinson's disease and other movement disorders: A systematic review2018
Professor Tiago Outeiro
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies2017
Professor Tiago Outeiro
Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity2017
Professor Tiago Outeiro
Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress2017
Professor Tiago Outeiro
Building Bridges through Science2017
Professor Tiago Outeiro
Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain2017
Professor Tiago Outeiro
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease2017
Professor Tiago Outeiro
Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors2017
Professor Tiago Outeiro
Contribution of Neuroepigenetics to Huntington’s Disease2017
Professor Tiago Outeiro
Copper(II) and the pathological H50Q α-synuclein mutant: Environment meets genetics2017
Professor Tiago Outeiro
Editorial: Molecular chaperones and neurodegeneration2017
Professor Tiago Outeiro
Epigenetics in Parkinson’s Disease2017
Professor Tiago Outeiro
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies2017
Professor Tiago Outeiro
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy2017
Professor Tiago Outeiro
Identification of a conserved gene signature associated with an exacerbated inflammatory environment in the hippocampus of aging rats2017
Professor Tiago Outeiro
Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways2017
Professor Tiago Outeiro
Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease2017
Professor Tiago Outeiro
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease2017
Professor Tiago Outeiro
Phycocyanin protects against Alpha-Synuclein toxicity in yeast2017
Professor Tiago Outeiro
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease2017
Professor Tiago Outeiro
Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity2017
Professor Tiago Outeiro
Serum lipid alterations in GBA-associated Parkinson's disease2017
Professor Tiago Outeiro
Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway2017
Professor Tiago Outeiro
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage2017
Professor Tiago Outeiro
Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutic Agents2017
Professor Tiago Outeiro
Synuclein misfolding as a therapeutic target2017
Professor Tiago Outeiro
Tau deletion promotes brain insulin resistance2017
Professor Tiago Outeiro
The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease2017
Professor Tiago Outeiro
The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes2017
Professor Tiago Outeiro
The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease2017
Professor Tiago Outeiro
Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease2017
Professor Tiago Outeiro
Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death2017
Professor Tiago Outeiro
Yeast models of Parkinson's disease-associated molecular pathologies2017
Professor Tiago Outeiro
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B2017
Professor Tiago Outeiro
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death2016
Professor Tiago Outeiro
A novel microfluidic cell co-culture platform for the study of the molecular mechanisms of Parkinson's disease and other synucleinopathies2016
Professor Tiago Outeiro
Analysis of protein oligomeric species by sucrose gradients2016
Professor Tiago Outeiro
C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease2016
Professor Tiago Outeiro
Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin2016
Professor Tiago Outeiro
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity2016
Professor Tiago Outeiro
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease2016
Professor Tiago Outeiro
Gene expression differences in peripheral blood of Parkinson's disease patients with distinct progression profiles2016
Professor Tiago Outeiro
Glycation in Parkinson's disease and Alzheimer's disease2016
Professor Tiago Outeiro
Glycation potentiates neurodegeneration in models of Huntington's disease2016
Professor Tiago Outeiro
Insulin-like growth factor-I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats2016
Professor Tiago Outeiro
LRRK2 Promotes Tau Accumulation, Aggregation and Release2016
Professor Tiago Outeiro
shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity2016
Professor Tiago Outeiro
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies2016
Professor Tiago Outeiro
The caffeine-binding adenosine A 2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function2016
Professor Tiago Outeiro
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation2016
Professor Tiago Outeiro
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity2016
Professor Tiago Outeiro
αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease2016
Professor Tiago Outeiro
(Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy2015
Professor Tiago Outeiro
Alpha-Synuclein Regulates Neuronal Levels of Manganese and Calcium2015
Professor Tiago Outeiro
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells2015
Professor Tiago Outeiro
Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism2015
Professor Tiago Outeiro
Isostructural Re(i)/99mTc(I) tricarbonyl complexes for cancer theranostics2015
Professor Tiago Outeiro
Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice2015
Professor Tiago Outeiro
Modeling Neuronal Pathology in Yeast: Insights into the Molecular Basis of Parkinson's Disease2015
Professor Tiago Outeiro
Mutant huntingtin alters Tau phosphorylation and subcellular distribution2015
Professor Tiago Outeiro
Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo2015
Professor Tiago Outeiro
Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour2015
Professor Tiago Outeiro
Small molecules detected by second-harmonic generation modulate the conformation of monomeric α-synuclein and reduce its aggregation in cells2015
Professor Tiago Outeiro
Super-resolution Microscopy of Clickable Amino Acids Reveals the Effects of Fluorescent Protein Tagging on Protein Assemblies2015
Professor Tiago Outeiro
The Interplay between Alpha-Synuclein Clearance and Spreading2015
Professor Tiago Outeiro
The sirtuin-2 inhibitor AK7 is neuroprotective in models of parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia2015
Professor Tiago Outeiro
Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment2014
Professor Tiago Outeiro
Challenges and promises in the development of neurotrophic factor-based therapies for parkinson's disease2014
Professor Tiago Outeiro
Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease2014
Professor Tiago Outeiro
DJ-1 interactions with a-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease2014
Professor Tiago Outeiro
DJ-1 modulates aggregation and pathogenesis in models of huntington's disease2014
Professor Tiago Outeiro
Integration of Single Cell Traps, Chemical Gradient Generator and Photosensors in a Microfluidic Platform for the Study of Alpha-Synuclein Toxicity in Yeast2014
Professor Tiago Outeiro
Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions2014
Professor Tiago Outeiro
Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells2014
Professor Tiago Outeiro
MeCP2: A novel huntingtin interactor2014
Professor Tiago Outeiro
Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator2014
Professor Tiago Outeiro
Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease2014
Professor Tiago Outeiro
Protein phosphorylation in neurodegeneration: Friend or foe?2014
Professor Tiago Outeiro
Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation2014
Professor Tiago Outeiro
Studying the Molecular Determinants of Protein Oligomerization in Neurodegenerative Disorders by Bimolecular Fluorescence Complementation2014
Professor Tiago Outeiro
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation2014
Professor Tiago Outeiro
The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity2014
Professor Tiago Outeiro
Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase2014
Professor Tiago Outeiro
α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner2014
Professor Tiago Outeiro
α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila2014
Professor Tiago Outeiro
Alpha-Synuclein and intracellular trafficking: Impact on the spreading of Parkinson's disease pathology2013
Professor Tiago Outeiro
Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy2013
Professor Tiago Outeiro
Epigenetics in Parkinson's and Alzheimer's diseases2013
Professor Tiago Outeiro
Harnessing the power of yeast to unravel the molecular basis of neurodegeneration2013
Professor Tiago Outeiro
Heat-mediated enrichment of α-synuclein from cells and tissue for assessing post-translational modifications2013
Professor Tiago Outeiro
Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice2013
Professor Tiago Outeiro
Inhibition of formation of α-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease2013
Professor Tiago Outeiro
Limelight on alpha-synuclein: Pathological and mechanistic implications in neurodegeneration2013
Professor Tiago Outeiro
Live-cell imaging of p53 interactions using a novel Venus-based bimolecular fluorescence complementation system2013
Professor Tiago Outeiro
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models2013
Professor Tiago Outeiro
Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo2013
Professor Tiago Outeiro
Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: Implications for disease mechanisms and interventions in synucleinopathies2013
Professor Tiago Outeiro
Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells2013
Professor Tiago Outeiro
PLK2 modulates α-synuclein aggregation in yeast and mammalian cells2013
Professor Tiago Outeiro
SIRT1 and SIRT2: Emerging targets in neurodegeneration2013
Professor Tiago Outeiro
Structural basis of kynurenine 3-monooxygenase inhibition2013
Professor Tiago Outeiro
The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease2013
Professor Tiago Outeiro
The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation2013
Professor Tiago Outeiro
The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival2013
Professor Tiago Outeiro
β-defensin genomic copy number does not influence the age of onset in huntington’s disease2013
Professor Tiago Outeiro
β-synuclein aggregates and induces neurodegeneration in dopaminergic neurons2013
Professor Tiago Outeiro
Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome2012
Professor Tiago Outeiro
Alpha-synuclein: From secretion to dysfunction and death2012
Professor Tiago Outeiro
Editorial on special topic: Sirtuins in metabolism, aging, and disease2012
Professor Tiago Outeiro
Epigenetic regulation of BACE1 in Alzheimer's disease patients and in transgenic mice2012
Professor Tiago Outeiro
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation2012
Professor Tiago Outeiro
High-throughput study of alpha-synuclein expression in yeast using microfluidics for control of local cellular microenvironment2012
Professor Tiago Outeiro
Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation2012
Professor Tiago Outeiro
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice2012
Professor Tiago Outeiro
SIRT2 as a therapeutic target for age-related disorders2012
Professor Tiago Outeiro
SNCA (α-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy2012
Professor Tiago Outeiro
Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context2012
Professor Tiago Outeiro
α-Synuclein modifies huntingtin aggregation in living cells2012